In this case, Jung and colleagues reported that loss of galectin-2 in gastric cancer cells was associated with the aggressiveness of cancer cells, revealing a commonality between galectin-2 and other galectins in playing contradictory roles in tumor progression, depending on the type. The gene discussed is LGALS2; the disease is gastric cancer.